The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo

British Journal of Cancer

Volumn 83, Issue 1, 2000, Pages 63-68

  Zhang, H T ^a   Scott, P A E ^b   Morbidelli, L ^c   Peak, S ^d   Moore, J ^a   Turley, H ^e   Harris, A L ^a   Ziche, M ^f   Bicknell, R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

^c UNIVERSITY OF FLORENCE   (Italy)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF SIENA   (Italy)

Author keywords

Angiogenesis; Differential splicing; Nuclear localization; Tumorigenesis; Vascular endothelial growth factor

Indexed keywords

AMINO ACID; ISOPROTEIN; NUCLEAR PROTEIN; VASCULOTROPIN;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CARCINOGENIC ACTIVITY; CORNEA; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROCESSING; RABBIT;

EID: 0034129125     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1279     Document Type: Article

References (24)

1. Acland P, Dixon M, Peters G and Dickson C (1990) Subcellular fate of the int-2 oncoprotein is determined by choice of initiation codon. Nature 343: 662-665
2. Bader T and Wiezerbin J (1994) Nuclear accumulation of interferon-γ. Proc Natl Acad Sci USA 91: 11831-11835
3. Bicknell R (1997) Mechanistic insights into tumour angiogenesis. In: Tumour Angiogenesis, Bicknell R, Lewis CE and Ferrara N (eds), pp. 19-28. Oxford University Press: Oxford
4. Carmeliet P, Ng Y-S, Nuyens D, Theilmeier G, Brusselmans K, Cornelissen I, Ehler E, Kakkar VV, Stalmans I, Mattot V, Perriard J-C, Dewerchin M, Flameng W, Nagy A, Lupu F, Moons L, Collen D, D'Amore PA and Shima DT (1999) Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nature Med 5: 495-502
5. Cheung N, Wong MP, Yuen ST, Leung SY and Chung LP (1998) Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon. Hum Pathol 29: 911-914
6. Coltrini D, Gualandris A and Nelli EE (1995) Growth advantage and vascularisation induced by basic fibrolblast growth factor overexpression in endometrial HEC-1-B cells: An export -dependent mechanism of action. Cancer Res 55: 4729-4738
7. Gimbrone MA Jr, Cotran RS, Leapman SB and Folkman J (1974) Tumor growth and neovascularisation: an experimental model using the rabbit cornea. J Natl Cancer Inst 52: 413-427
8. Gitay-Goren H, Cohen T, Tessler S, Soker S, Gengrinovitch S, Rockwell P, Klagsbrun M, Levi BZ and Neufeld G (1996) Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. J Biol Chem 271: 5519-5523
9. Grutzkau A, Kruger-Krasagakes S, Baumeister H, Schwarz C, Kogel H, Welker P, Lippert U, Henz BM and Moller A (1998) Synthesis, storage and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cell: implications for the biological significance of VEGF206. Mol Biol Cell 9: 875-884
10. Houck KA, Ferrara N, Winer J, Cachianes G, Li B and Leung DW (1991) The vascular endothelial growth factor family: identification of a fourth molecular species and characterisation of alternative splicing of RNA. Mol Endocrinol 5: 1806-1814
11. Houck KA, Leung DW, Rowland AM, Winer J and Ferrara N (1992) Dual regulation of vascular endothelial growth factor bioavailability genetic and proteolytic mechanisms. J Biol Chem 267: 26031-26037
12. Keyt BA, Berleau LT, Nguyen HV, Chen H, Heinsohn H, Vandlen R and Ferrara N (1996) The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 271: 7788-7795
13. Lei J, Jiang A and Pei D (1998) Identification and characterisation of a new splicing variant of vascular endothelial growth factor: VEGF183. Biochim Biophys Acta 1443: 400-406
14. Neufeld G, Cohen T, Gengrinovitch S and Poltorak Z (1999) Vascular endothelial growth factor and its receptors. FASEB J 13: 9-22
15. Park JE, Keller GA and Ferrara N (1993) The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF Mol Biol Cell 4. 1317-1326
16. Relf M, LeJeune S, Scott PAE, Fox S, Smith K, Leek R, Moghaddam A, Whitehouse R, Bicknell R and Harris AL (1997) Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, transforming growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57: 963-969
17. Robbins J, Dilworth SM, Laskey RA and Dingwall C (1991) Two independent basic domains in nucleoplasmin nuclear targeting sequence: Identification of a class of bipartite nuclear targeting sequence. Cell 64: 615-623
18. Siemeister G, Schnurr B, Mohrs K, Schachtele C, Marme D and Martiny-Baron G (1996) Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli. Biochem Biophys Res Commun 222. 249-255
19. Smith K, Houlbrook S, Greenall M, Carmichael J and Harris AL (1993) Topoisomerase IIα coamplification with erbB-2 in human primary breast cancer and breast cancer cell lines relationship to m-AMSA and mitoxantrone sensitivity Oncogene 8: 933-938
20. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarwicz D, Fiddes JC and Abraham JA (1991) The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954
21. Turley H, Scott PAE, Watts VM, Bicknell B, Harris AL and Gatler KG (1998) Expression of YEGF in routinely fixed material using a new monoclonal antibody VG1. J Pathol 186: 313-318
22. Zhang H, Craft P, Scott PAE, Ziche M, Weich HA, Harris AL and Bicknell R (1995) Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst 87: 213-219
23. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P and Ledda F (1994) Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94: 2036-2044
24. Ziche M, Morbidelli L, Choudhuri R, Zhang H-T, Donnini S, Granger HJ and Bicknell R (1997) Nitric oxide-synthase lies downstream of vascular endothelial growth factor but not basic fibroblast growth factor induced angiogenesis. J Clin Invest 99: 2625-2634